Adenovirus vectors: biology, design, and production.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current Topics in Microbiology and Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-662-05599-1_10PMID 14674606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variables Affecting In Vivo Performance of High-Capacity Adenovirus Vectors

  2002cited by this paper
• Safety of Local Delivery of Low- and Intermediate-Dose Adenovirus Gene Transfer Vectors to Individuals with a Spectrum of Morbid Conditions

  2002cited by this paper
• Analysis of Risk Factors for Local Delivery of Low- and Intermediate-Dose Adenovirus Gene Transfer Vectors to Individuals with a Spectrum of Comorbid Conditions

  2002cited by this paper
• A Pilot Study of In Vivo Liver-Directed Gene Transfer with an Adenoviral Vector in Partial Ornithine Transcarbamylase Deficiency

  2002cited by this paper
• Tumor-specific transcriptional targeting of suicide gene therapy

  2002cited by this paper
• Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer.

  2001cited by this paper
• Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.

  2001cited by this paper
• Development of a FLP/frt system for generating helper-dependent adenoviral vectors.

  2001cited by this paper
• Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination

  2001cited by this paper
• A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.

  2001cited by this paper
• Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector

  2001cited by this paper
• A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.

  2001cited by this paper
• A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.

  2001cited by this paper
• Adenovirus-Mediated Gene Transfer of VEGF121 Improves Lower-Extremity Endothelial Function and Flow Reserve

  2001cited by this paper
• Tissue-Specific, Tumor-Selective, Replication-Competent Adenovirus Vector for Cancer Gene Therapy

  2001cited by this paper
• Long-Term Efficacy after [E1-, polymerase-] Adenovirus-Mediated Transfer of Human Acid-α-Glucosidase Gene into Glycogen Storage Disease Type II Knockout Mice

  2001cited by this paper
• Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.

  2001cited by this paper
• Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.

  2000cited by this paper
• Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

  2000cited by this paper
• A Phase I Study of Intralesional Administration of an Adenovirus Vector Expressing the HSV-1 Thymidine Kinase Gene (AdV.RSV-TK) in Combination with Escalating Doses of Ganciclovir in Patients with Cutaneous Metastatic Malignant Melanoma

  2000cited by this paper
• An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

  2000cited by this paper
• A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

  2000cited by this paper
• Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

  2000cited by this paper
• A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.

  2000cited by this paper
• Tumor-Specific, Replication-Competent Adenovirus Vectors Overexpressing the Adenovirus Death Protein

  2000cited by this paper
• Double Suicide Gene Therapy Augments the Antitumor Activity of a Replication-Competent Lytic Adenovirus through Enhanced Cytotoxicity and Radiosensitization

  2000cited by this paper
• A Novel, Conditionally Replicative Adenovirus for the Treatment of Breast Cancer That Allows Controlled Replication of E1a-Deleted Adenoviral Vectors

  2000cited by this paper
• Production of first generation adenovirus vectors: a review

  2000cited by this paper
• Targeting adenovirus

  2000cited by this paper
• Efficient Transformation of Primary Human Amniocytes by E1 Functions of Ad5: Generation of New Cell Lines for Adenoviral Vector Production

  2000cited by this paper
• Effects of Stuffer DNA on Transgene Expression from Helper-Dependent Adenovirus Vectors

  1999cited by this paper
• A Novel Tumor-Specific Replication-Restricted Adenoviral Vector for Gene Therapy of Hepatocellular Carcinoma

  1999cited by this paper
• Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

  1999cited by this paper
• Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.

  1999cited by this paper
• Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.

  1999cited by this paper
• E4ORF3 Requirement for Achieving Long-Term Transgene Expression from the Cytomegalovirus Promoter in Adenovirus Vectors

  1999cited by this paper
• Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

  1998cited by this paper
• An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.

  1998cited by this paper
• Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degeneration.

  1998cited by this paper
• Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity

  1998cited by this paper
• Production and Characterization of Improved Adenovirus Vectors with the E1, E2b, and E3 Genes Deleted

  1998cited by this paper
• High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1-Antitrypsin with Negligible Toxicity

  1998cited by this paper
• New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent Adenoviruses

  1998cited by this paper
• Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.

  1998cited by this paper
• In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted

  1998cited by this paper
• High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity.

  1998cited by this paper
• Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver

  1997cited by this paper
• Construction of adenovirus vectors through Cre-lox recombination

  1997cited by this paper
• Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo

  1997cited by this paper
• Construction of an adenovirus type 7a E1A- vector

  1997cited by this paper
• Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

  1997cited by this paper
• Effect of the E4 region on the persistence of transgene expression from adenovirus vectors

  1997cited by this paper
• Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells.

  1997cited by this paper
• A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging

  1997cited by this paper
• Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.

  1997cited by this paper
• Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector

  1997cited by this paper
• Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo

  1997cited by this paper
• Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5

  1997cited by this paper
• In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.

  1996cited by this paper
• Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.

  1996cited by this paper
• Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.

  1996cited by this paper
• An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

  1996cited by this paper
• A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

  1996cited by this paper
• A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

  1996cited by this paper
• In Vivo Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral Genes

  1996cited by this paper
• Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo

  1996cited by this paper
• The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.

  1995cited by this paper
• A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells.

  1995cited by this paper
• Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector.

  1995cited by this paper
• Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2a

  1994cited by this paper
• Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis

  1994cited by this paper
• Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

  1994cited by this paper
• Emergence of Early Region 1-Containing Replication-Competent Adenovirus in Stocks of Replication-Defective Adenovirus Recombinants (ΔE1 + ΔE3) During Multiple Passages in 293 Cells

  1994cited by this paper
• Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment

  1993cited by this paper
• Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

  1993cited by this paper
• cis and trans requirements for the selective packaging of adenovirus type 5 DNA

  1992cited by this paper
• The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

  1992cited by this paper
• Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant

  1990cited by this paper
• Eight ‘Musts’ for Biotechnology

  1988cited by this paper
• Development of adenovirus vectors for the expression of heterologous genes.

  1988cited by this paper
• Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae.

  1987cited by this paper
• Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome

  1987cited by this paper
• Identification of a cellular transcription factor involved in E1A trans-activation.

  1986cited by this paper
• Regulation of adenovirus gene expression in human WI38 cells by an E1B-encoded tumor antigen

  1986cited by this paper
• Overproduction of the protein product of a nonselected foreign gene carried by an adenovirus vector.

  1985cited by this paper
• An adenovirus vector system used to express polyoma virus tumor antigens.

  1985cited by this paper
• Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity

  1984cited by this paper
• Adenovirus—Simian Virus 40 Interactions

  1984cited by this paper
• Cis-acting induction of adenovirus transcription.

  1983cited by this paper
• Palindromic adenovirus type 5-simian virus 40 hybrid

  1983cited by this paper
• An unusual symmetric recombinant between adenovirus type 12 DNA and human cell DNA.

  1981cited by this paper
• Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells.

  1980cited by this paper
• Encapsidation of adenovirus 16 DNA is directed by a small DNA sequence at the left end of the genome.

  1980cited by this paper
• Physical mapping of a large-plaque mutation of adenovirus type 2

  1979cited by this paper
• Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

  1979cited by this paper
• The structure and expression of two defective adenovirus 2/simian virus 40 hybrids.

  1978cited by this paper
• Viral DNA sequences from incomplete particles of human adenovirus type 7.

  1977cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper
• Genome structure of incomplete particles of adenovirus

  1976cited by this paper
• Isolation of Two Plaque Variants from the Adenovirus Type 2-Simian Virus 40 Hybrid Population Which Differ in Their Efficiency in Yielding Simian Virus 40

  1970cited by this paper

• Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives

  2025cites this paper
• Current Status of Poultry Recombinant Virus Vector Vaccine Development

  2024cites this paper
• Construction and Evaluation of the Immunogenicity and Protective Efficacy of Recombinant Replication-Deficient Human Adenovirus-5 Expressing Genotype VII Newcastle Disease Virus F Protein and Infectious Bursal Disease Virus VP2 Protein

  2023cites this paper
• Treatment strategies for HIV infection with emphasis on role of CRISPR/Cas9 gene: Success so far and road ahead.

  2022cites this paper
• Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics

  2022cites this paper
• Comparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies

  2021cites this paper
• Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges.

  2021cites this paper
• Recent Advances in CRISPR/Cas9 Delivery Strategies

  2020cites this paper
• Recent Advances in CRISPR/Cas9 Delivery Strategies

  2020cites this paper
• Virally vectored vaccine delivery: medical needs, mechanisms, advantages and challenges.

  2017cites this paper
• Controlled Gene Delivery Systems for Articular Cartilage Repair

  2017cites this paper
• A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression

  2017cites this paper
• Loss of HLA class I expression in prostate cancer and restoration using adenoviral and adeno-associated viral vectors

  2016cites this paper
• Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions.

  2015cites this paper
• Waking the Sleeping Giant: Gene Therapy in Decline?

  2015cites this paper
• Long‐term glycemic control with hepatic insulin gene therapy in streptozotocin‐diabetic mice

  2015cites this paper
• Cutaneous Cell- and Gene-Based Therapies for Inherited and Acquired Skin Disorders

  2014cites this paper
• Viral Gene Therapy Vectors

  2014cites this paper
• Beta-2-microglobulin gene transfer in hla class i deficient tumor cells using recombinant adenovirus

  2014cites this paper
• Optimal delivery of therapeutic genes to pancreatic islets.

  2013cites this paper
• Improvement of oncolytic adenovirus vectors through genetic capsid modifications

  2012cites this paper
• Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

  2012cites this paper
• Adenovirus vectors and subviral particles for protein and peptide delivery.

  2012cites this paper
• Vector Specific Tolerance Induction for Airwary Gene Therapy

  2012cites this paper
• Gene-Delivered Butyrylcholinesterase Is Prophylactic against the Toxicity of Chemical Warfare Nerve Agents and Organophosphorus Compounds

  2011cites this paper
• Suppression of RNA Interference by Virus-Associated RNA of Adenovirus Serotypes Ad4, Ad5, Ad11 and Ad12

  2011cites this paper
• Administration of adenovirus encoding anti-CD20 antibody gene induces B-cell deletion and alleviates lupus in the BWF1 mouse model.

  2011cites this paper
• Replication-competent adenovirus 11p vector as a new oncolytic agent

  2011cites this paper
• Adenovirus vector production and purification.

  2010cites this paper
• Generation of Cell Lines to Complement Adenovirus Vectors using Recombination-Mediated Cassette Exchange

  2010cites this paper
• Alcock Vectors at Supraphysiological Temperatures in Carbohydrate Glass Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine

  2010cites this paper
• Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass

  2010cites this paper
• Gene therapy for osteoarthritis

  2010cites this paper
• The potential of a novel Adenovirus vector for vaccination.

  2010influential citation
• An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations.

  2010cites this paper
• Efficient adenovirus‐mediated gene transfer to gastric tissue by oral administration

  2009cites this paper
• Gene therapy of the rheumatic diseases: 1998 to 2008

  2009cites this paper
• The 5′-end heterogeneity of adenovirus virus-associated RNAI contributes to the asymmetric guide strand incorporation into the RNA-induced silencing complex

  2009cites this paper
• Clinical trials for glioblastoma multiforme using adenoviral vectors.

  2009cites this paper
• La terapia genica nella riparazione cartilaginea

  2009cites this paper
• Gene transfer vehicle and use therefor

  2009cites this paper
• Gene therapy science and technology

  2009cites this paper
• Adenoviral Control of RNAi/miRNA Pathways in Human Cells

  2008cites this paper
• Simultaneous inhibition of the constitutively activated nuclear factor κB and of the Interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells

  2008cites this paper
• Perspectives on the use of gene therapy for chronic joint diseases.

  2008cites this paper
• Down-regulations of both HSP 27 and TGF-β expression overcome the resistance of hepatocellular carcinoma cells to Sorafenib

  2008cites this paper
• Spatial patterning of gene expression using surface-immobilized recombinant adenovirus

  2008cites this paper
• Modelling and treating Huntington’s disease: Generation of high-capacity adenovirus vectors to express normal and mutant huntingtin and to block huntingtin expression by short hairpin interference RNA

  2008cites this paper
• Stem cells and periodontal regeneration.

  2008cites this paper
• Generation of adenovirus-mediated anti-CD20 antibody and its effect on B-cell deletion in mice and nonhuman primate cynomolgus monkey

  2008cites this paper
• Adenoviruses : molecular biology

  2008cites this paper
• Adeno-associated viral delivery of a metabolically regulated insulin transgene to hepatocytes.

  2007cites this paper
• High-Capacity Adenoviral Vector-Mediated Reduction of Huntingtin Aggregate Load In Vitro and In Vivo

  2007cites this paper
• GENETIC RE-TARGETING AND DE-TARGETING OF ADENOVIRUS TYPE 5 IN ORDER TO CREATE VECTORS FOR GENE THERAPY

  2007cites this paper
• Virus-based gene therapy strategies for bone regeneration.

  2007cites this paper
• Modification of Adenovirus Capsid with a Designed Protein Ligand Yields a Gene Vector Targeted to a Major Molecular Marker of Cancer

  2007cites this paper
• Chapter 2 – Mouse Adenoviruses

  2007cites this paper
• Potential of helper-dependent adenoviral vectors in modulating airway innate immunity.

  2007cites this paper
• Increased tumor localization and reduced immune response to adenoviral vector formulated with the liposome DDAB/DOPE.

  2007cites this paper
• Cellular receptors for species B adenoviruses

  2007cites this paper
• Stem cells and periodontal regeneration.

  2006cites this paper
• Principles of Gene Manipulation and Genomics

  2006cites this paper
• Biosafety and Viral Gene Transfer Vectors

  2006cites this paper
• Quantitative analysis of adenoviral vector modification of a cytokine-mediated cell death decision

  2006cites this paper
• Transposon-Assisted Cloning and Traceless Mutagenesis of Adenoviruses: Development of a Novel Vector Based on SpeciesD

  2006cites this paper
• Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.

  2006cites this paper
• Gene therapeutic approaches-transfer in vivo.

  2006cites this paper
• Adenovirus RID (cid:2)(cid:3) Complex Inhibits Lipopolysaccharide Signaling without Altering TLR4 Cell Surface Expression†

  2006cites this paper
• In vivo application of adenoviral vectors purified by a Taqman Real Time PCR-supported chromatographic protocol.

  2006cites this paper
• Molecular Mechanisms of Melanoma Metastasis

  2006cites this paper
• Adenovirus RIDαβ Complex Inhibits Lipopolysaccharide Signaling without Altering TLR4 Cell Surface Expression

  2006cites this paper
• Dendritic cell based cancer vaccines using adenovirally mediated expression of the HER-2/neu gene and apoptotic tumor cells expressing heat shock protein 70

  2006cites this paper
• Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10.

  2006cites this paper
• Development of Group B Adenoviruses as Gene Transfer Vectors

  2006cites this paper
• An oncolytic adenovirus expressing soluble transforming growth factor-β type II receptor for targeting breast cancer: in vitro evaluation

  2006cites this paper
• Development and Assessment of Human Adenovirus Type 11 as a Gene Transfer Vector

  2005cites this paper
• Use of Adenovirus-Mediated Gene Transfer to Facilitate Biological Annotation of Novel Genes

  2005cites this paper
• Evaluation of (76)Br-FBAU as a PET reporter probe for HSV1-tk gene expression imaging using mouse models of human glioma.

  2005cites this paper
• Vector-Mediated Cancer Gene Therapy

  2005cites this paper
• Adenovirus-Based Genetic Vaccines for Biodefense

  2005cites this paper
• Gene Therapy for Inherited Diseases of the Central Nervous System

  2005cites this paper
• Transcriptionally targeted adenovirus vectors.

  2005cites this paper
• Regulation of Fanconi anaemia complementation group a (Fanca) by gonadotropin releasing hormone : a role for Fanca in reproduction

  2005cites this paper
• Novel molecular approaches to cystic fibrosis gene therapy.

  2005cites this paper
• XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes.

  2005cites this paper
• Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients?

  2005cites this paper
• Considerations for Use of Recombinant Adenoviral Vectors: Dose Effect on Hepatic Cytochromes P450

  2005cites this paper
• Gene therapy: twenty-first century medicine.

  2005cites this paper
• Vector-mediated cancer gene therapy: An overview

  2005cites this paper
• Feasibility of an antiviral clinical trial requiring cross-country shipment of conjunctival adenovirus cultures and recovery of infectious virus

  2004cites this paper
• Adenovirus species B: receptors, tropism and hematopoietic cells

  2004cites this paper
• Non-viral delivery of ribozymes for cancer gene therapy

  2004cites this paper
• Virally vectored vaccine delivery : medical needs , mechanisms , advantages and challenges

  year unknowncites this paper